BENSON HILL INC (BHIL)

US0824901039 - Common Stock

0.2275  +0.02 (+8.44%)

After market: 0.2298 +0 (+1.01%)

Fundamental Rating

2

Overall BHIL gets a fundamental rating of 2 out of 10. We evaluated BHIL against 93 industry peers in the Food Products industry. Both the profitability and financial health of BHIL have multiple concerns. While showing a medium growth rate, BHIL is valued expensive at the moment.



0

1. Profitability

1.1 Basic Checks

BHIL had negative earnings in the past year.
In the past year BHIL has reported a negative cash flow from operations.
In the past 5 years BHIL always reported negative net income.
BHIL had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

The Return On Assets of BHIL (-41.98%) is worse than 80.43% of its industry peers.
BHIL has a worse Return On Equity (-134.06%) than 81.52% of its industry peers.
Industry RankSector Rank
ROA -41.98%
ROE -134.06%
ROIC N/A
ROA(3y)-30.36%
ROA(5y)-33.1%
ROE(3y)-83.39%
ROE(5y)-77.15%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Looking at the Gross Margin, with a value of 4.99%, BHIL is doing worse than 84.78% of the companies in the same industry.
In the last couple of years the Gross Margin of BHIL has declined.
The Profit Margin and Operating Margin are not available for BHIL so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 4.99%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-13.76%
GM growth 5Y-43.1%

2

2. Health

2.1 Basic Checks

BHIL does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for BHIL has been increased compared to 1 year ago.
BHIL has a better debt/assets ratio than last year.

2.2 Solvency

BHIL has an Altman-Z score of -1.76. This is a bad value and indicates that BHIL is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -1.76, BHIL is doing worse than 78.26% of the companies in the same industry.
BHIL has a Debt/Equity ratio of 0.14. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of BHIL (0.14) is better than 75.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.14
Debt/FCF N/A
Altman-Z -1.76
ROIC/WACCN/A
WACC11.51%

2.3 Liquidity

A Current Ratio of 1.17 indicates that BHIL should not have too much problems paying its short term obligations.
The Current ratio of BHIL (1.17) is worse than 67.39% of its industry peers.
BHIL has a Quick Ratio of 1.17. This is a bad value and indicates that BHIL is not financially healthy enough and could expect problems in meeting its short term obligations.
BHIL has a Quick ratio (0.92) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.17
Quick Ratio 0.92

4

3. Growth

3.1 Past

The earnings per share for BHIL have decreased by 0.00% in the last year.
Looking at the last year, BHIL shows a very strong growth in Revenue. The Revenue has grown by 43.46%.
Measured over the past years, BHIL shows a very strong growth in Revenue. The Revenue has been growing by 156.06% on average per year.
EPS 1Y (TTM)0%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q0%
Revenue 1Y (TTM)43.46%
Revenue growth 3Y100.08%
Revenue growth 5Y156.06%
Revenue growth Q2Q143.4%

3.2 Future

The Earnings Per Share is expected to grow by 22.53% on average over the next years. This is a very strong growth
The Revenue is expected to decrease by -27.36% on average over the next years. This is quite bad
EPS Next Y57.74%
EPS Next 2Y29.59%
EPS Next 3Y22.53%
EPS Next 5YN/A
Revenue Next Year-71.06%
Revenue Next 2Y-45.23%
Revenue Next 3Y-27.36%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for BHIL. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for BHIL. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

BHIL's earnings are expected to grow with 22.53% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y29.59%
EPS Next 3Y22.53%

0

5. Dividend

5.1 Amount

BHIL does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

BENSON HILL INC

NYSE:BHIL (5/16/2024, 7:04:01 PM)

After market: 0.2298 +0 (+1.01%)

0.2275

+0.02 (+8.44%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap48.23M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -41.98%
ROE -134.06%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 4.99%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.72
Health
Industry RankSector Rank
Debt/Equity 0.14
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.17
Quick Ratio 0.92
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)0%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y57.74%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)43.46%
Revenue growth 3Y100.08%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y